Home › NDC Lookup › RxCUI directory › RxCUI 1046815

Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopo... — RxCUI 1046815

RxNorm drug concept · Semantic clinical drug
RxCUI 1046815 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1046815
Official nameAtropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine HBr 0.0065 MG Oral Tablet
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)73 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenobarbital: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Phenobarbital is mainly used to control seizures — including generalized tonic-clonic seizures (sometimes called grand mal seizures) and partial seizures. It's also used as a sedat...
  • What is phenobarbital actually used for?
  • Please don't stop it on your own. Phenobarbital can cause physical dependence, and stopping it suddenly — especially after taking it for a while — can trigger serious withdrawal sy...
  • Can I just stop taking phenobarbital if I feel better?
📖 Read our full Phenobarbital guide →

🕸️ Concept Web — How Atropine sulfate 0.0194 MG / hyoscyamine sulfate... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet RxCUI 1046815

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 8

    The active substance itself — no strength, form, or brand attached yet.

    • Atropine 1223
    • Hyoscyamine 153970
    • Phenobarbital 8134
    • Scopolamine 9601
    • Atropine / hyoscyamine / phenobarbital / scopolamine 689606
    • Atropine sulfate 153971
    • Hyoscyamine sulfate 1225
    • Scopolamine hydrobromide 9603
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Donnatal 115141
    • Phenohytro 1739882
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet 374677
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet 2647221
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product 1154679
    • Atropine / hyoscyamine / phenobarbital / scopolamine Pill 1154680
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product 2661270
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Pill 2659870
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet [Donnatal] 368551
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet [Phenohytro] 1739884
    • +9 more in this family
  4. Clinical & branded drugs 8

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 26 of 35 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atropine sulfate 0.0194 MG SCDC · 1046805
  • Hyoscyamine sulfate 0.1037 MG SCDC · 1046806
  • Phenobarbital 16.2 MG SCDC · 316479
  • Scopolamine hydrobromide 0.0065 MG SCDC · 1046807
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet SCDF · 374677
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Tablet SCDFP · 2647221
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product SCDG · 1154679
  • Atropine / hyoscyamine / phenobarbital / scopolamine Pill SCDG · 1154680
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product SCDGP · 2661270
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Pill SCDGP · 2659870

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1046815 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50742-0667-01 100 TABLET in 1 BOTTLE, PLASTIC (50742-667-01) Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Ingenus Pharmaceuticals, LLC 2021-08-01
59212-0425-04 4 TABLET in 1 BOTTLE, PLASTIC (59212-425-04) Donnatal Advanz Pharma (US) Corp. 1980-12-30
59212-0425-10 100 TABLET in 1 BOTTLE, PLASTIC (59212-425-10) Donnatal Advanz Pharma (US) Corp. 1980-12-30
75826-0118-00 1000 TABLET in 1 BOTTLE, PLASTIC (75826-118-00) Phenohytro Winder Laboratories, LLC 2016-02-29
75826-0118-10 100 TABLET in 1 BOTTLE, PLASTIC (75826-118-10) Phenohytro Winder Laboratories, LLC 2016-02-29
Observed labelers: Advanz Pharma (US) Corp. (2) · Winder Laboratories, LLC (2) · Ingenus Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$1.2548
Range $1.2548–$1.2548 · middle 50% $1.2548–$1.2548 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.